Current clinical guidance reminds us that phenotypic presentations of type 2 diabetes are highly variable but that there are common unmet needs and conformities in therapeutic strategy [2,3,4]
It isnt active in the body until its absorbed in the gastrointestinal (GI) tract and converted to the active component dextroamphetamine, which belongs to the class of drugs known as amphetamines
Evaluate gut function and correct constipation or dysbiosis before starting long-term hormonal therapy
The real-world results we see in clinic come from combining a GLP-1 medication with structured nutrition advice, regular weighing-in, and a clinician available to manage side effects
327 In the inflammatory environment, the M1 to M2 shift promoted by GLP-1 is crucial for reducing the expression of inflammatory factors such as IL-6, TNF-, and iNOS
Moreover, liraglutide also had effects on reducing the incidence of MI in high-risk patients for T2DM, and may improve the clinical outcomes of MI [24]
